This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
Vocabulary Work Group | Maturity Level: N/A | Ballot Status: Informative |
FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)
{ "resourceType": "CodeSystem", "id": "v2-0252", "meta": { "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablecodesystem" ] }, "text": { "status": "additional", "div": "<div>!-- Snipped for Brevity --></div>" }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status", "valueString": "External" }, { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm", "valueInteger": 0 } ], "url": "http://hl7.org/fhir/v2/0252", "identifier": { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.18.147" }, "version": "2.8.2", "name": "v2 Causality Observations", "status": "active", "experimental": false, "publisher": "HL7, Inc", "contact": [ { "telecom": [ { "system": "url", "value": "http://hl7.org" } ] } ], "description": "FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)", "caseSensitive": false, "valueSet": "http://hl7.org/fhir/ValueSet/v2-0252", "content": "complete", "concept": [ { "code": "AW", "display": "Abatement of event after product withdrawn", "designation": [ { "language": "nl", "value": "Vermindering gebeurtenis na terugtrekken product" } ] }, { "code": "BE", "display": "Event recurred after product reintroduced", "designation": [ { "language": "nl", "value": "Gebeurtenis trad opnieuw op na herintroductie product" } ] }, { "code": "DR", "display": "Dose response observed", "designation": [ { "language": "nl", "value": "Dosis reactie geobserveerd" } ] }, { "code": "EX", "display": "Alternative explanations for the event available", "designation": [ { "language": "nl", "value": "Alternatieve verklaringen voor gebeurtenis beschikbaar" } ] }, { "code": "IN", "display": "Event occurred after product introduced", "designation": [ { "language": "nl", "value": "Gebeurtenis trad op na introductie product" } ] }, { "code": "LI", "display": "Literature reports association of product with event", "designation": [ { "language": "nl", "value": "Literatuur vermeldt koppeling van product met gebeurtenis" } ] }, { "code": "OE", "display": "Occurrence of event was confirmed by objective evidence", "designation": [ { "language": "nl", "value": "Optreden van gebeurtenis is bevestigd door objectief bewijs" } ] }, { "code": "OT", "display": "Other", "designation": [ { "language": "nl", "value": "Anders" } ] }, { "code": "PL", "display": "Effect observed when patient receives placebo", "designation": [ { "language": "nl", "value": "Effect geobserveerd wanneer patiënt placebo krijgt" } ] }, { "code": "SE", "display": "Similar events in past for this patient", "designation": [ { "language": "nl", "value": "Vergelijkbare gebeurtenissen in verleden voor deze patiënt" } ] }, { "code": "TC", "display": "Toxic levels of product documented in blood or body fluids", "designation": [ { "language": "nl", "value": "Toxische niveaus van product gedocumenteerd in bloed of lichaamssappen" } ] } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.